A passionate group of Scientists and Physicians dedicated to addressing human diseases using novel data analyses techniques to develop new tools for early detection of infectious diseases.
Celleome Biosciences is a data driven company committed to innovations in diagnostic medicine. Next Generation Sequencing (NGS) and Artificial Intelligence (AI) hold the key to early and accurate diagnosis of diseases including infectious and lifestyle diseases, exponentially increasing in prevalence in the the developing world.
Using our core expertise in AI and data analysis methodologies, we are using NGS data derived from Tuberculosis (TB) patients to develop a rapid, economical, and easy to use low cost diagnostic tool for accurately diagnosing Latent Tuberculosis Infectious disease (LTBI) and Active Tuberculosis (ATB).